Viridian Therapeutics, Inc. (VRDN)
USD 18.93
(-9.08%)
USD 18.93
(-9.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 314 Thousand | 1.77 Million | 2.96 Million | 1.05 Million | 4.46 Million | 8.38 Million |
| Cost of Revenue | 1.32 Million | 755 Thousand | 620 Thousand | 28.3 Million | 32.79 Million | 30.42 Million |
| Gross Profit | -1 Million | 1.01 Million | 2.34 Million | -27.25 Million | -28.33 Million | -22.03 Million |
| Operating Expenses | 254.76 Million | 136.07 Million | 82.69 Million | 41.56 Million | 46.44 Million | 41.47 Million |
| Selling, General and Administrative Expenses | 94.99 Million | 35.18 Million | 25.8 Million | 13.26 Million | 11.64 Million | 11.04 Million |
| Research and Development Expenses | 159.76 Million | 100.89 Million | 56.88 Million | 28.3 Million | 34.79 Million | 30.42 Million |
| Other Expenses | - | - | - | 69.86 Million | - | - |
| Cost and Expenses | 254.76 Million | 136.07 Million | 82.69 Million | 41.56 Million | 46.44 Million | 41.47 Million |
| Operating Income | -254.45 Million | -134.3 Million | -79.72 Million | -110.38 Million | -41.97 Million | -33.08 Million |
| Interest Expense | 1.84 Million | 486 Thousand | 3000.00 | 508 Thousand | 835 Thousand | 873 Thousand |
| Income Tax Expense | - | -4.43 Million | 3000.00 | 269 Thousand | 547 Thousand | 1.25 Million |
| Earnings before Tax | -237.73 Million | -129.87 Million | -79.41 Million | -110.71 Million | -41.87 Million | -32.7 Million |
| Net Income | -237.73 Million | -125.44 Million | -79.41 Million | -110.98 Million | -42.42 Million | -32.7 Million |
| Earnings Per Share Basic | -5.31 | -3.91 | -6.66 | -31.20 | -20.31 | -16.57 |
| Earnings Per Share Diluted | -5.31 | -3.91 | -6.66 | -31.20 | -20.31 | -16.57 |
| Weighted Average Shares Outstanding | 44.75 Million | 32.08 Million | 11.91 Million | 3.55 Million | 2.08 Million | 1.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.75 Million | 32.08 Million | 11.91 Million | 3.55 Million | 2.08 Million | 1.97 Million |
| Gross Margin | -3.21 | 0.57 | 0.79 | -25.96 | -6.35 | -2.63 |
| EBIT Margin | -747.02 | -73.02 | -26.76 | -38.42 | -9.20 | -3.80 |
| Profit Margin | -757.11 | -70.79 | -26.80 | -105.70 | -9.51 | -3.90 |
| EBITDA | -234.56 Million | -128.63 Million | -78.79 Million | -109.66 Million | -40.75 Million | -31.54 Million |
| Earnings Before Tax Margin | -810.35 | -75.79 | -26.91 | -105.12 | -9.41 | -3.95 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 72 Thousand | 72 Thousand | 314 Thousand | 72 Thousand | 72 Thousand | 72 Thousand |
| Cost of Revenue | 5.79 Million | 345 Thousand | 1.32 Million | 350 Thousand | 335 Thousand | 432 Thousand |
| Gross Profit | -5.71 Million | -273 Thousand | -1 Million | -278 Thousand | -263 Thousand | -360 Thousand |
| Operating Expenses | 72.25 Million | 55.96 Million | 254.76 Million | 71.55 Million | 51.29 Million | 59.34 Million |
| Selling, General and Administrative Expenses | 16.06 Million | 15.02 Million | - | 32.99 Million | 20.91 Million | 19.26 Million |
| Research and Development Expenses | 56.19 Million | 40.94 Million | - | 38.55 Million | 30.38 Million | 40.08 Million |
| Other Expenses | -5.79 Million | - | - | - | - | - |
| Cost and Expenses | 72.25 Million | 55.96 Million | 254.76 Million | 71.55 Million | 51.29 Million | 59.34 Million |
| Operating Income | -72.18 Million | -55.89 Million | -254.45 Million | -71.47 Million | -51.22 Million | -59.27 Million |
| Interest Expense | 597 Thousand | -587 Thousand | 1.84 Million | 916 Thousand | -600 Thousand | 166 Thousand |
| Income Tax Expense | 72.18 Million | -145 Thousand | 18.56 Million | 5.53 Million | -135 Thousand | 4.37 Million |
| Earnings before Tax | -64.99 Million | -48.54 Million | -237.73 Million | -66.86 Million | -47.66 Million | -55.06 Million |
| Net Income | -64.99 Million | -48.54 Million | -237.73 Million | -66.86 Million | -47.66 Million | -55.06 Million |
| Earnings Per Share Basic | -1.02 | -0.79 | - | -1.35 | -1.09 | -1.27 |
| Earnings Per Share Diluted | -1.02 | -0.79 | - | -1.35 | -1.09 | -1.27 |
| Weighted Average Shares Outstanding | 63.85 Million | 61.09 Million | 44.75 Million | 49.68 Million | 43.65 Million | 43.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 63.85 Million | 61.09 Million | 44.75 Million | 49.68 Million | 43.65 Million | 43.25 Million |
| Gross Margin | -79.43 | -3.79 | -3.21 | -3.86 | -3.65 | -5.00 |
| EBIT Margin | -892.42 | -776.35 | - | -913.81 | -711.44 | -760.62 |
| Profit Margin | -902.68 | -674.19 | -757.11 | -928.61 | -661.94 | -764.76 |
| EBITDA | -64.25 Million | -55.89 Million | - | -65.79 Million | -51.22 Million | -54.76 Million |
| Earnings Before Tax Margin | -1002.60 | -776.35 | -810.35 | -992.75 | -711.44 | -823.26 |
DHANBANK
AIEV
6482
BBNI
DT3
CAMRF